The federal contract IDV award SPE2DM20D6518 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Cardinal Health 200, LLC, a subsidiary of Cardinal Health, Inc. The contract, valued up to $4,999,999, enables DLA to rapidly procure a wide range of medical and pharmaceutical products under Federal Supply Group 46 and Federal Supply Class 6515. This includes surgical dressings, drugs, biologicals, and other medical consumables to support military treatment facilities and DoD customers in DLA Region 1. The contract has an ultimate completion date of August 27, 2027, allowing for the ongoing delivery of essential medical supplies and pharmaceuticals to the U.S. military healthcare system. As a major supplier of medical and pharmaceutical products, Cardinal Health 200, LLC leverages its parent company's extensive distribution network and expertise to meet the complex needs of government customers, including the Department of Defense, Department of Veterans Affairs, and other federal agencies. The company has been awarded multiple delivery orders against various IDCs, demonstrating its critical role in supporting the federal government's healthcare supply chain.
In addition to the DLA contract, Cardinal Health, Inc. and its subsidiaries hold several other significant federal IDV awards, including a single-award IDC with the Department of Veterans Affairs for the provision of radiopharmaceutical products, and a single-award IDC with the VA National Acquisition Center for the supply of Lurasidone Hydrochloride tablets. These flexible contracting vehicles showcase Cardinal Health's ability to efficiently deliver a diverse array of medical products and pharmaceuticals to meet the ongoing needs of military, VA, and other government healthcare providers.
Generated 11/19/24, 9:11 AM